FATE Fate Therapeutics Inc

USD 4.06 0.00 0
Icon

Fate Therapeutics Inc (FATE) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 4.06

0.00 (0.00)%

USD 0.43B

2.02M

USD 6.30(+55.17%)

USD 0.00 (-100.00%)

Icon

FATE

Fate Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 4.06
0.00 0
Take a Tour

Fate Therapeutics Inc (FATE) Stock Forecast

Show ratings and price targets of :
USD 6.30
(+55.17%)

Based on the Fate Therapeutics Inc stock forecast from 8 analysts, the average analyst target price for Fate Therapeutics Inc is USD 6.30 over the next 12 months. Fate Therapeutics Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Fate Therapeutics Inc is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Fate Therapeutics Inc’s stock price was USD 4.06. Fate Therapeutics Inc’s stock price has changed by +6.84% over the past week, -41.75% over the past month and -34.20% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...